SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J. G. Gurney, J. K. Bass, A. Onar-Thomas, J. Huang, M. Chintagumpala, E. Bouffet, T. Hassall, S. Gururangan, J. A. Heath, S. Kellie, R. Cohn, M. J. Fisher, A. P. Panandiker, T. E. Merchant, A. Srinivasan, C. Wetmore, I. Qaddoumi, C. F. Stewart, G. T. Armstrong, A. Broniscer, A. Gajjar, Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma, Neuro-Oncology, 2014, 16, 6, 848

    CrossRef

  2. 2
    Maria G. Riga, Leonidas Chelis, Stylianos Kakolyris, Stergios Papadopoulos, Sofia Stathakidou, Eleni Chamalidou, Nikolaos Xenidis, Kyriakos Amarantidis, Prokopios Dimopoulos, Vasilios Danielides, Transtympanic Injections of N-acetylcysteine for the Prevention of Cisplatin-induced Ototoxicity, American Journal of Clinical Oncology, 2013, 36, 1, 1

    CrossRef

  3. 3
    V. Vendramini, B. Robaire, S. M. Miraglia, Amifostine-doxorubicin association causes long-term prepubertal spermatogonia DNA damage and early developmental arrest, Human Reproduction, 2012, 27, 8, 2457

    CrossRef

  4. 4
    Jennifer Gains, Henry Mandeville, Nicholas Cork, Penelope Brock, Mark Gaze, Ten challenges in the management of neuroblastoma, Future Oncology, 2012, 8, 7, 839

    CrossRef

  5. 5
    Arnold C. Paulino, Mark Lobo, Bin S. Teh, M. Fatih Okcu, Michael South, E. Brian Butler, Jack Su, Murali Chintagumpala, Ototoxicity After Intensity-Modulated Radiation Therapy and Cisplatin-Based Chemotherapy in Children With Medulloblastoma, International Journal of Radiation Oncology*Biology*Physics, 2010, 78, 5, 1445

    CrossRef

  6. 6
    Howard M. Katzenstein, Kay W. Chang, Mark Krailo, Zhengjia Chen, Milton J. Finegold, Jon Rowland, Marleta Reynolds, Alberto Pappo, Wendy B. London, Marcio Malogolowkin, Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma, Cancer, 2009, 115, 24
  7. 7
    Roger Y. Tsang, Turki Al-Fayea, Heather-Jane Au, Cisplatin Overdose, Drug Safety, 2009, 32, 12, 1109

    CrossRef

  8. 8
    Nazan Çetingül, Levent Midyat, Mehmet Kantar, Bengü Demirağ, Serap Aksoylar, Savaş Kansoy, Cytoprotective effects of amifostine in the treatment of childhood malignancies, Pediatric Blood & Cancer, 2009, 52, 7
  9. 9
    M. Fevzi Ozkaynak, Indira Sahdev, Thomas G. Gross, John E. Levine, Alexandra C. Cheerva, Michael K. Richards, Marta K. Rozans, Peter J. Shaw, Richard P. Kadota, A Pilot Study of Addition of Amifostine to Melphalan, Carboplatin, Etoposide, and Cyclophosphamide With Autologous Hematopoietic Stem Cell Transplantation in Pediatric Solid Tumors–A Pediatric Blood and Marrow Transplant Consortium Study, Journal of Pediatric Hematology/Oncology, 2008, 30, 3, 204

    CrossRef

  10. 10
    Lynn S. Ashby, Matthew M. Troester, William R. Shapiro, Central nervous system tumors, Update on Cancer Therapeutics, 2006, 1, 4, 475

    CrossRef

  11. 11
    Roderick Skinner, Preventing platinum-induced ototoxicity in children—is there a potential role for sodium thiosulfate?, Pediatric Blood & Cancer, 2006, 47, 2
  12. 12
    Edward A. Neuwelt, Kristin Gilmer-Knight, Cynthia Lacy, H. Stacy Nicholson, Dale F. Kraemer, Nancy D. Doolittle, Gregory W. Hornig, Leslie L. Muldoon, Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption, Pediatric Blood & Cancer, 2006, 47, 2
  13. 13
    Neyssa Marina, Kay W. Chang, Marcio Malogolowkin, Wendy B. London, A. Lindsay Frazier, Richard B. Womer, Frederick Rescorla, Deborah F. Billmire, Mary M. Davis, Elizabeth J. Perlman, Roger Giller, Stephen J. Lauer, Thomas A. Olson, Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors, Cancer, 2005, 104, 4